ALS News
Researchers Find a Specific Biomarker for ALS that May Improve the Diagnostic Process
ALS NEWS - January 19, 2021
Diagnosing Amyotrophic Lateral Sclerosis (ALS) can take between 9 to 12 months. Finding a “biomarker” or a physical attribute that confirms ALS onse... Read More
Medication Using Gold Crystals with Promising Potential for ALS Treatment
ALS NEWS - January 19, 2021
Over 40% of the participants in the phase 2 clinical trial for CNM-Au8 show improvements in health. CNM-AU8 is a gold nanocrystal suspension treatment designed ... Read More
New ALS Disability Bill Passed Congress, Waving the Five-Month Waiting Period for Social Security Disability Insurance
ALS NEWS - December 08, 2020
After 4 years of challenging work and 54,000 phone calls, letters, and emails to Congress from advocates like you, Congress passed a law that wai... Read More
FDA Grants Orphan Drug Status to Promising Treatment for ALS Called SLS-005
ALS NEWS - November 25, 2020
Seelos Therapeutics is working on a treatment called SLS-005 or trehalose to treat Amyotrophic Laterals Sclerosis. The drug proves to be eff... Read More
What is Gene Therapy and How is it Changing the Future for ALS?
ALS NEWS - October 29, 2020
Amyotrophic lateral sclerosis, or ALS, is a neurological disease that causes the death of motor neurons. More commonly known as Lou Gehrig’s disease, ALS ... Read More
A New Advancement in Gene Therapy for ALS Patients
ALS NEWS - October 27, 2020
In a press release this week Ionis Pharmaceuticals, a leader in gene therapy treatments, announced its first gene therapy medication designed to treat... Read More
Small ALS Research Teams are Breaking New Ground in ALS Treatment
ALS NEWS - October 19, 2020
Life with ALS is not an easy one. There are only a small number of treatments available for those diagnosed with this rapidly progressing neurological... Read More
Phase II ALS Clinical Trial Produces Promising Results for AMX0035
ALS NEWS - September 29, 2020
The Pharmaceutical company AMYLYX recently released promising results for the ALS drug AMX0035 after Phase II clinical trials were completed. The results d... Read More
New Promising Neurological Treatment for Alzheimer's used in ALS in Phase 2 Clinical Trials
ALS NEWS - September 13, 2020
Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More
A Potential ALS Treatment is Back on Track After COVID-19 Disruption
ALS NEWS - August 31, 2020
This global pandemic has put a lot of things on pause. From sports to drug research, the world is doing a complete reboot. One of the biggest setbacks is fundin... Read More
Clene Nanomedicine Develops New Therapy for ALS Using Gold Nanocrystals
ALS NEWS - August 29, 2020
Clene Nanotechnologies, a Utah based company, has developed a nano-therapetic for neurodegenerative disorders including ALS. To date, Clene's preclinical tr... Read More
New Promising Neurological Treatment Involves ALS in Phase 2 Clinical Trials
ALS NEWS - August 28, 2020
Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects 400,000 people worldwide. It is characterized by progressive loss... Read More
ALS Clinical Trials Actively Recruiting
ALS NEWS - August 05, 2020
ALS Crowd is dedicated to connecting researchers, doctors, patients, and caregivers/family members in order to support, educate, and find patterns in therapy to... Read More
